Funds · TRAW

Who owns TRAW?

Institutional ownership of Traws Pharma Inc. from Form 13F, Q2 2026

34 institutional managers reported holding Traws Pharma Inc. (TRAW) in Form 13F filings for Q2 2026, with 6,156,331 shares worth $5.2M. The largest reported holder was Orbimed Advisors LLC. Managers that filed both quarters added a net 2,536,534 shares (+70.1%). 13 opened new positions and 6 sold out.

Funds holding
34
Value held
$5.2M
New / sold out
13 / 6
Net shares, same filers
+70.1%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of TRAW

FundValueShare of 13F holdingsSharesMove
Orbimed Advisors LLC$1.0M19.5%1,203,260Added
Ally Bridge Group (NY) LLC$663K12.8%786,236New
Adage Capital Partners GP, L.l.c.$616K11.9%730,000Unchanged
ADAR1 Capital Management, LLC$504K9.7%597,729Added
Lynx1 Capital Management LP$472K9.1%559,470Added
Ikarian Capital, LLC$403K7.8%478,142Trimmed
Sphera Funds Management LTD.$336K6.5%398,486New
Vanguard Capital Management LLC$278K5.4%330,049Added
Jane Street Group, LLC$182K3.5%216,006Added
Alyeska Investment Group, L.P.$139K2.7%164,376New
Boothbay Fund Management, LLC$113K2.2%133,936Trimmed
Geode Capital Management, LLC$94K1.8%111,365Added
HRT Financial LP$76K1.5%91,220New
Kynam Capital Management, LP$71K1.4%84,400New
Dauntless Investment Group, LLC$68K1.3%80,574Trimmed
Vanguard Fiduciary Trust Co$46K0.9%54,511Added
Northern Trust Corp$32K0.6%37,454New
State Street Corp$22K0.4%25,802Unchanged
XTX Topco Ltd$15K0.3%18,092New
SG Americas Securities, LLC$12K0.2%14,524New
Virtu Financial LLC$11K0.2%12,579New
BlackRock, Inc.$8K0.2%9,941Trimmed
Tower Research Capital LLC (TRC)$4K0.1%5,142Added
Huntington National Bank$4K0.1%4,676New
UBS Group AG$3K0.1%3,451Trimmed

Share of 13F holdings is each fund's shares as a share of the 6,156,331 TRAW shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $3.1M and sold $1.6M; 9 added and 8 trimmed.

Questions about TRAW ownership

Who owns TRAW stock?
34 institutional investment managers reported TRAW positions in their Form 13F filings for Q2 2026, holding 6,156,331 shares worth $5.2M in total. Orbimed Advisors LLC reported the largest position.
Are funds buying or selling TRAW?
In Q2 2026, 13 managers opened new TRAW positions, 9 added, 8 trimmed and 6 sold out. Managers that filed in both quarters added a net 2,536,534 shares.
How current is this TRAW institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to TRAW by CUSIP. Options are left out. TRAW news and filings · TRAW insider trades · Top funds